TITLE

Exposure to chemotherapy late in pregnancy had little effect on placenta

PUB. DATE
April 2009
SOURCE
Hem/Onc Today;4/10/2009, Vol. 10 Issue 7, p23
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses a study on the effects of the timing and type of chemotherapy used during pregnancy on the placenta.
ACCESSION #
37292863

 

Related Articles

  • A Rare Case of Liver Metastasis in Malignant Melanoma of the Vagina. Dasari, Papa; Habeebullah, Syed // Journal of Gynecologic Surgery;Mar2009, Vol. 25 Issue 1, p29 

    A 46-year-old multiparous lady, who underwent a subtotal hysterectomy for an adherent placenta during her last childbirth 6 years ago, presented with mass and bleeding per vaginum of 2 months' duration. Her general condition was good and her gynecologic examination revealed a blackish...

  • ACTUALIDAD EN EL DIAGNÓSTICO Y MANEJO DEL ACRETISMO PLACENTARIO. G., Omar Dueñas; O., Hugo Rico; B., Mario Rodriguez // Revista Chilena de Obstetricia y Ginecología;2007, Vol. 72 Issue 4, p266 

    Placenta accreta supposes a special situation that increases the fetal and maternal morbirnortality of considerable form. Thanks all new arrival methods as the image of magnetic resonance, the cystoscopy, serum markers, doppler ultrasound, etc., the prenatal diagnostic is feasible. The...

  • The Function of Cytochrome P450 1A1 Enzyme (CYP1A1) and Aryl Hydrocarbon Receptor (AhR) in the Placenta. Stejskalova, Lucie; Pavek, Petr // Current Pharmaceutical Biotechnology;May2011, Vol. 12 Issue 5, p715 

    No abstract available.

  • P-0186 ANTITUMOR ACTIVITY OF PLACENTA-DERIVED MESENCHYMAL STEM CELLS ON RAT COLON CANCER MODEL. Halyna, Kuznietsova; Anna, Svitina; Volodymyr, Shablii; Volodymyr, Rybalchenko // Annals of Oncology;Jun2014, Vol. 25 Issue suppl_2, pii70 

    No abstract available.

  • In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Silberstein, Lev; Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Saito, Toshiki I.; Celso, Cristina Lo; Tsuyuzaki, Hitoshi; Sato, Tatsuyuki; Côté, Daniel; Sykes, Megan; Strom, Terry B.; Scadden, David T.; Lin, Charles P. // Nature;6/9/2011, Vol. 474 Issue 7350, p216 

    Stem cells reside in a specialized regulatory microenvironment or niche, where they receive appropriate support for maintaining self-renewal and multi-lineage differentiation capacity. The niche may also protect stem cells from environmental insults including cytotoxic chemotherapy and perhaps...

  • Human Placental Mesenchymal Stem Cells (pMSCs) Play a Role as Immune Suppressive Cells by Shifting Macrophage Differentiation from Inflammatory M1 to Anti-inflammatory M2 Macrophages. Abumaree, M.; Jumah, M.; Kalionis, B.; Jawdat, D.; Khaldi, A.; Abomaray, F.; Fatani, A.; Chamley, L.; Knawy, B. // Stem Cell Reviews & Reports;Oct2013, Vol. 9 Issue 5, p620 

    Background: Mesenchymal stem cells (MSCs) have a therapeutic potential in tissue repair because of capacity for multipotent differentiation and their ability to modulate the immune response. In this study, we examined the ability of human placental MSCs (pMSCs) to modify the differentiation of...

  • Treatment of duodenal ulcer associated with chronic gastric erosions. Smith, J.M. // JAMA: Journal of the American Medical Association;2/5/92, Vol. 267 Issue 5, p645 

    Abstracts a study by Y.V. Vasiliev and K.M. Rishi which investigated three groups of patients who received chemotherapy for duodenal ulcer and associated gastric erosion. Medications involved in the study; Relief of pylorduodenal pain; More.

  • Integration of EGFR inhibitors with radiochemotherapy. Nyati, Mukesh K.; Morgan, Meredith A.; Feng, Felix Y.; Lawrence, Theodore S. // Nature Reviews Cancer;Dec2006, Vol. 6 Issue 12, p974 

    A correction to the article "Integration of EGFR inhibitors with radiochemotherapy," published in the December 2006 issue of the periodical "Nature Reviews Cancer" is presented.

  • A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. Candelaria, Myrna; Gallardo-Rincón, Dolores; Arce, Claudia; Cetina, Lucely; Aguilar-Ponce, Jose Luis; Arrieta, Oscar; Serrano, Alberto; Perez-Plasencia, Carlos; Gonzalez-Fierro, Aurora; De la Cruz-Hernandez, Erik; Revilla-Vazquez, Alma; Chavez-Blanco, Alma; Trejo-Becerril, Catalina; Perez-Cardenas, Enrique; Taja-Chayeb, Lucia; Camargo, Maria F.; Robles, Elizabeth; Dueñas-Gonzalez, Alfonso // BMC Cancer;2007 Supplement 1, Vol. 7, pA27 

    An abstract of the article "A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors," by Myrna Candelaria, Claudia Arce, Oscar Arrieta, Alberto Serrano, and colleagues is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics